Accessibility Menu
Smith & Nephew Plc logo

Smith & Nephew Plc(OTC) SNNUF

Market Cap$12.97BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+178%
5 Year-10%
1 Year-10%
1 Month+17%
$15.48
+6.69%
+0.97Today
Smith & Nephew Plc last closing stock price
MetricPriceDate
Last closeUSD 15.482026-08-13
Smith & Nephew Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 15.482026-08-03
1 month+16.65%USD 13.272026-07-14
3 month+3.55%USD 14.952026-05-12
Year to date-4.78%USD 16.262025-12-31
1 year-10.32%USD 17.262025-08-13
3 year+16.55%USD 13.282023-08-14
5 year-10.08%USD 17.212021-08-12
Since inception+178.38%USD 5.562003-06-26

Smith & Nephew Plc Financials at a Glance

Market Cap

$12.97BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$12.34B

Net Income (TTM)

$1.13B

EPS (TTM)

$0.73

P/E Ratio

20.86

Dividend

$0.39

Beta (Volatility)

0.13 (Low)

Price

$15.48

Volume

30

Open

$15.48

Previous Close

$15.48

Daily Range

$15.48 - $15.48

52-Week Range

$13.10 - $18.50

Estimated Earnings Date

Feb 23, 2027

SNNUF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Smith & Nephew Plc

Smith & Nephew plc is a global medical technology enterprise focused on developing, manufacturing, and commercializing a wide range of medical devices. The company operates in key areas such as orthopedics, sports medicine, and advanced wound management, providing innovative solutions to healthcare providers worldwide.

Products and Services
  • Knee and hip implants for orthopedic procedures
  • Joint repair solutions and arthroscopic enabling technologies
  • Advanced wound management products for chronic and acute wounds
Growth Outlook
  • Revenue of $3.05 billion in Q2 2026, showing strong demand
  • Net income of $298.6 million in Q2 2026, reflecting profitability
  • Consistent investment in R&D, with $147.8 million in Q2 2026
Financial Highlights
  • Trailing twelve-month revenue of $12.2 billion, indicating robust performance
  • Dividend yield of 2.62%, appealing for income-focused investors
  • Operating income margin of 15.47%, showcasing operational efficiency
Smith & Nephew plc has established itself as a leader in the medical technology sector, with a diverse product portfolio that addresses critical healthcare needs. The company's commitment to innovation and quality positions it well for future growth, supported by strong financial performance and a focus on research and development. With a solid market presence and a history of profitability, Smith & Nephew presents an intriguing opportunity for potential investors.
AI Generated • Aug 12, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

18,362

CEO

Deepak S Nath, PhD

Website

www.smith-nephew.com

Headquarters

Watford, HR WD18 8YE, GB

SNNUF Financials

Key Financial Metrics (TTM)

Gross Margin

68.18%

Operating Margin

16.69%

Net Income Margin

10.08%

Return on Equity

12.25%

Return on Capital

12.53%

Return on Assets

5.81%

Earnings Yield

4.79%

Dividend Yield

2.51%

Payout Ratio

52.32%

Stock Overview

Market Cap

$12.97BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

838.04M

Volume

30

Avg. Volume

1.34K

Financials (TTM)

Gross Profit

$8.46B

Operating Income

$1.96B

EBITDA

$3.07B

Operating Cash Flow

$2.48B

Capital Expenditure

-$829.02M

Free Cash Flow

$1.65B

Cash & ST Invst.

$753.12M

Total Debt

$3.78B

Smith & Nephew Plc Performance Analysis

Smith & Nephew Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 5,215,000,0000.1%
20232023-12-31USD 5,549,000,0006.4%
20242024-12-31USD 5,810,000,0004.7%
20252025-12-31USD 6,164,000,0006.1%
Smith & Nephew Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-315.5%
Q22025-06-28-0.7%
Q42025-12-3112.8%
Q22026-06-30-8.6%
Smith & Nephew Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.26-57.2%
20232023-12-31USD 0.3018.0%
20242024-12-31USD 0.4756.1%
20252025-12-31USD 0.7252.2%
Smith & Nephew Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-12.0%
Q22025-06-2850.0%
Q42025-12-3121.2%
Q22026-06-30-12.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.05B

+8.0%

Gross Profit

$2.16B

+9.6%

Gross Margin

70.91%

N/A

Market Cap

$12.97BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$706.51K

N/A

Employees

18,362

N/A

Net Income

$298.62M

+39.5%

EBITDA

$767.73M

+27.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$753.12M

+32.6%

Total Debt

$3.78B

+3.4%

Accounts Receivable

$1.52B

+8.5%

Inventory

$2.11B

-15.3%

Long Term Debt

$3.21B

-2.0%

Short Term Debt

$572.33M

+50.6%

Return on Assets

5.81%

N/A

Return on Invested Capital

11.81%

N/A

Free Cash Flow

$256.24M

+288.2%

Operating Cash Flow

$443.49M

+86.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GIKLYGrifols, S.A.
$5.10+0.00%
FMCQFFresenius Medical Care AG
$51.44+0.00%
SBMFFSino Biopharmaceutical Limited
$0.61+0.00%
BMXMFbioMérieux S.A.
$82.66+4.65%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About SNNUF

What is the current price of Smith & Nephew Plc?

Smith & Nephew Plc is trading at $15.48 per share.

What is the 52-week range for Smith & Nephew Plc?

Over the past 52 weeks, Smith & Nephew Plc has traded between $13.10 and $18.50.

How much debt does Smith & Nephew Plc have?

As of the most recent reporting period, Smith & Nephew Plc reported total debt of $3.33B.

How much cash does Smith & Nephew Plc have on hand?

Smith & Nephew Plc reported $557.00M in cash and cash equivalents in its most recent financial results.

What is Smith & Nephew Plc’s dividend yield?

Smith & Nephew Plc currently has a dividend yield of 2.51%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services